Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
Separate neuronal pathways mediate social, attentional behaviors
Here is a roundup of autism-related news and research spotted around the web for the week of 20 July.
Separate neuronal pathways mediate social, attentional behaviors
Here is a roundup of autism-related news and research spotted around the web for the week of 20 July.
In memoriam: Susumu Tonegawa, ‘intellectual giant’
He won the Nobel Prize for his work on immunology and then went on to define the field of learning and memory.
In memoriam: Susumu Tonegawa, ‘intellectual giant’
He won the Nobel Prize for his work on immunology and then went on to define the field of learning and memory.